The estimated Net Worth of Robert Alexander is at least 18.6 百万$ dollars as of 2 June 2021. Robert Alexander owns over 63,597 units of Allakos Inc stock worth over 202,072$ and over the last 6 years he sold ALLK stock worth over 5,849,016$. In addition, he makes 12,559,300$ as Chief Executive Officer、 Director at Allakos Inc.
Robert has made over 4 trades of the Allakos Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 63,597 units of ALLK stock worth 5,849,016$ on 2 June 2021.
The largest trade he's ever made was selling 63,597 units of Allakos Inc stock on 2 June 2021 worth over 5,849,016$. On average, Robert trades about 6,496 units every 6 days since 2018. As of 2 June 2021 he still owns at least 331,266 units of Allakos Inc stock.
You can see the complete history of Robert Alexander stock trades at the bottom of the page.
Dr. Robert D. Alexander Ph.D. serves as Chief Executive Officer, Director of the Company. Dr. Alexander previously served as our President from November 2017 through August 2019 and as a member of our board of directors from December 2012 until June 2013. From December 2013 to April 2017, Dr. Alexander served as Chief Executive Officer of ZS Pharma (acquired by AstraZeneca in December 2015), where he also served as a member of the board of directors, including as Chairman from March 2013 to March 2014. From November 2005 to March 2013, Dr. Alexander served as a Director at Alta Partners, a venture capital firm in life sciences. In addition, he acted as Executive Chairman and interim Chief Executive Officer of SARcode Biosciences (acquired by Shire plc in April 2013), a biopharmaceutical company. During his time at Alta, he led investments in SARcode Biosciences, Lumena Pharmaceuticals, ZS Pharma and Allakos. Previously, Dr. Alexander was a Principal in MPM Capital’s BioEquities fund where he sourced opportunities and led due diligence efforts for both public and private investments. Dr. Alexander also previously worked in the Business Development group at Genentech (now a member of the Roche Group), a biotechnology company, where he was responsible for sourcing and screening product opportunities based on scientific merit and strategic fit, leading diligence teams and negotiating terms and definitive agreements. He is currently a director at Allena Pharmaceuticals. Dr. Alexander joined Genentech after completing his post-doctoral fellowship at Stanford University in the Pathology department. He also holds a Ph.D. with a focus in immunology from the University of North Carolina and a B.A. in zoology from Miami University of Ohio.
As the Chief Executive Officer、 Director of Allakos Inc, the total compensation of Robert Alexander at Allakos Inc is 12,559,300$. There are no executives at Allakos Inc getting paid more.
Robert Alexander is 50, he's been the Chief Executive Officer、 Director of Allakos Inc since 2019. There are 8 older and 1 younger executives at Allakos Inc. The oldest executive at Allakos Inc is Steven James, 62, who is the Independent Director.
Robert's mailing address filed with the SEC is 825 INDUSTRIAL ROAD, SUITE 500, , SAN CARLOS, CA, 94070.
Over the last 6 years, insiders at Allakos Inc have traded over 246,100,922$ worth of Allakos Inc stock and bought 5,181,222 units worth 35,384,176$ . The most active insiders traders include Paul Edward Walker、Group, Llc Green Jeremy Red...、Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of 114,372$. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth 87,935$.
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
Allakos Inc executives and other stock owners filed with the SEC include: